Tumor xenografts experiments suggested that silencing PVT1 sensitized NSCLC (Non-small-cell lung carcinoma) cells to radiotherapy in vivo, and this could be reverted by miR-195 inhibitor (41). Here, PVT1 is linked to non-small cell lung carcinoma.